Myrtelle key facts
as of Oct 2026- Operator of a gene therapy company intended to offer innovative clinical trials for the treatment of the rare monogenic disorder.
- Myrtelle is valued at approximately $134.0M as of Oct 2026 (last reported valuation).
- It has raised $82.6M across 4 recorded rounds; the latest was Early Stage VC ($30.5M) in Dec 2025.
- Notable investors include Panacea Venture, F1 BioVentures, Panacea Capital (California).
- Myrtelle has filed 4 Form Ds with the SEC since 2021, most recently Mar 2025 ($7.5M sold to 1 investors).
- Status: Privately Held (backing).
Myrtelle's last reported valuation, Dec 2022. Nothing priced has surfaced since.
- ·Watch Myrtelle: the Monday email on marks, rounds and moves
Myrtelle funding rounds
4 roundsWho backs Myrtelle
3Myrtelle valuation
Myrtelle's last reported valuation was $134 million in Dec 2022. No priced round, secondary trade or fund mark has surfaced since.
How much has Myrtelle raised?
Myrtelle has raised $82.6 million across 4 recorded rounds since 2021. The largest was a $7.5 million debt round in Mar 2025; the most recent was a $30.5 million early-stage round in Dec 2025.
Myrtelle has filed 4 Form Ds with the SEC since 2021, most recently in Mar 2025 ($7.5 million sold to 1 investor).
Myrtelle investors
3 investors are on record for Myrtelle, including Panacea Venture, F1 BioVentures and Panacea Capital (California). The early-stage round in Dec 2025 drew 21 investors.
About Myrtelle
Operator of a gene therapy company intended to offer innovative clinical trials for the treatment of the rare monogenic disorder. The company helps to address an array of diseases with white matter involvement, including demyelinating diseases and ASPA-associated disorders with rare CNS diseases, enabling healthcare professionals to develop and deliver novel treatments for devastating disorders of the central nervous system and transform the treatment of neurological diseases that improve the quality of life and longevity.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2020
- Employees
- 13
- Website
- myrtellegtx.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.